PET OEF reactivity for hemodynamic compromise in occlusive vascular disease

Journal of Neuroimaging

Volumn 17, Issue 1, 2007, Pages 54-60

  Nemoto, Edwin M ^a,c   Yonas, Howard ^a   Pindzola, Ronda R ^a   Kuwabara, Hiroto ^b   Sashin, Donald ^a   Chang, Yuefang ^a   Jovin, Tudor ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c B 804 PUH ^*  (United States)

Author keywords

Cerebral blood flow; Oxygen uptake; Stroke; Stroke risk

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEMISPHERE; HEMODYNAMICS; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; OXYGEN CONSUMPTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROVOCATION TEST; WHITE MATTER;

ACETAZOLAMIDE; ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; BRAIN; CAROTID STENOSIS; CEREBRAL ARTERIAL DISEASES; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; VASODILATION;

EID: 33846088404     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2006.00080.x     Document Type: Article

References (32)

1. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion. Can acetazolamide test predict it? Stroke 2001;32:2110-2116.
2. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion. A Xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857-1862.
3. Yonas H, Smith H, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-489.
4. Grubb RL, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055-1060.
5. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. Am J Neuroradiol 1995;16:563-570.
6. Yamauchi H, Fukuyama H,Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999;40:1992-1998.
7. Nemoto EM, Yonas H, Kuwabara H, et al. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 2004;24:1081-1089.
8. Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry 2004;75:33-37.
9. Kuroda S, Shiga T, Houkin K, Ishikawa T, Katoh C, Tamkai N, Iwasaki Y. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease. Stroke 2006;37:393-398.
10. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633.
11. Bruhn H, Kleindschmidt A, Boecker H, Merboldt KD, Hanicke W, Frahm J. The effect of acetazolamide on regional cerebral oxygenation at rest and under stimulation as assessed by MRI. J Cereb Blood Flow Metab 1994;14:742-748.
12. Ohta S, Meyer E, Thompson CJ. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab 1992;12:179-192.
13. 15O autoradiography and positron emission tomography with respect to the dispersion of the input function. J Cereb Blood Flow Metab 1986;6:536-545.
14. Mintun MA, Raichle ME, Martin WRW, Herscovitch P. Brain oxygen utilization measured with 0-15 radiotracers and positron emission tomography. J Nuc Med 1983;25:177-187.
15. Ohta S, Meyer E, Fujita H, Reutens DC, Evans A, Gjedde A. Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values. J Cereb Blood Flow Metab 1966;16:765-780.
16. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985;5(4):600-608.
17. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Variability of cerebral blood volume and oxygen extraction: stages of cerebral hemodynamic impairment revisited. Brain 2002;125(Pt 3):595-607.
18. Ito H, Ibaraki M, Kanno I, Fukuda H, Miura S. Changes in cerebral blood flow and cerebral oxygen metabolism during neural activation measured by positron emission tomography: comparison with blood oxygenation level-dependent contrast measured by functional magnetic resonance imaging. J Cereb Blood Flow Metab 2005;25(3):371-377.
19. Okazawa H, Yamuchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472-1479.
20. Demolis P, Florence G, Thomas L, Dinh YRT, Giudicelli J-F, Seylaz J. Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study. Stroke 2000;31:508-515.
21. Derdeyn CP. Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? Stroke 2000;31(9):2271-2272.
22. Nemoto EM, Yonas H. Revisiting the question, "is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? Stroke 2001;32(5):1234-1237.
23. Ito H, Kanno I, Iida H, Hatazawa J, Shimosegawa E, Tamura H, Okudera T. Arterial cerebral blood volume in humans measured by positron emission tomography. Ann Nucl Med 2001;15:111-116.
24. Ito H, Ibaraki N, Kanno I, Fukuda H, Mura S. Changes in the arterial fraction of human cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography. J Cereb Blood Flow Metab 2005;25:852-857.
25. Garcia JH, Lassen NA,Weiller C, Sperling B, Nakagawara J., Ischemic stroke and incomplete infarction. Stroke 1996;27(4):761-765.
26. Baron JC.Depression of energy metabolism in distant brain structures: studies with positron emission tomography in stroke patients. Semin Neurol 1989;9:281-285.
27. Baron JC. Using PET to identify carotid occlusion patients at high risk of subsequent stroke: further insights. J Neurol Neurosurg Psychiatry 2004;75:1659-1660.
28. Yamauchi H, Fukuyama H, Yamaguchi S, Miyoshi T, Kimura J, Konishi J. High-intensity area in the deep white matter indicating hemodynamic compromise in internal carotid artery occlusive disorders. Arch Neurol 1991;48:1067-1071.
29. Krapf H,Wider B, Skalej M. Small rosary like infarctions in the centrum semiovale suggest hemodynamic failure. Am J Neuroradiol 1998;19:1479-1474.
30. Del Sette M, Eliasziw M, Streifler JY, Hachinski VC, Fox AJ, Barnett HJ. Internal borderzone infarction: a marker for severe stenosis in patients with symptomatic internal carotid artery disease. For the North American Symptomatic Carotid Endarectomy (NASCET) Group. Stroke 2000;31:631-636.
31. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991;29(3):231-240.
32. Nemoto EM, Yonas H, Chang YF [Letter]. Stages and thresholds of hemodynamic failure. Stroke 2003;34:2-3.